BRAF Modulates Lipid Use and Accumulation
Authors:
- Jacqueline A. TurnerJTJacqueline A. Turner
- Emily L. PatonEPEmily L. Paton
- Robert Van GulickRGRobert Van Gulick
- Davide StefanoniDSDavide Stefanoni
- Francesca CendaliFCFrancesca Cendali
- Julie ReiszJRJulie Reisz
- Richard P. TobinRTRichard P. Tobin
- Martin McCarterMMMartin McCarter
- Angelo D’alessandroAngelo D’alessandro
- Raul M. TorresRTRaul M. Torres
- William A. RobinsonWRWilliam A. Robinson
- Kasey L. CoutsKCKasey L. Couts
Open Access
Abstract
There is increasing evidence that oxidative metabolism and fatty acids play an important role in BRAF-driven tumorigenesis, yet the effect of BRAF mutation and expression on metabolism is poorly understood. We examined how BRAF mutation and expression modulates metabolite abundance. Using the non-transformed NIH3T3 cell line, we generated cells that stably overexpressed BRAF V600E or BRAF WT. We found that cells expressing BRAF V600E were enriched with immunomodulatory lipids. Further, we found a unique transcriptional signature that was exclusive to BRAF V600E expression. We also report that BRAF V600E mutation promoted accumulation of long chain polyunsaturated fatty acids (PUFAs) and rewired metabolic flux for non-Warburg behavior. This cancer promoting mutation further induced the formation of tunneling nanotube (TNT)-like protrusions in NIH3T3 cells that preferentially accumulated lipid droplets. In the plasma of melanoma patients harboring the BRAF V600E mutation, levels of lysophosphatidic acid, sphingomyelin, and long chain fatty acids were significantly increased in the cohort of patients that did not respond to BRAF inhibitor therapy. Our findings show BRAF V600 status plays an important role in regulating immunomodulatory lipid profiles and lipid trafficking, which may inform future therapy across cancers.Keywords
This publication has 49 references indexed in Scilit:
- The Combination of Novel Targeted Molecular Agents and Radiation in the Treatment of Pediatric GliomasFrontiers in Oncology, 2013
- The molecular basis of induction and formation of tunneling nanotubesCell and tissue research, 2012
- Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disordersHaematologica, 2011
- BRAFMutations in Hairy-Cell LeukemiaNew England Journal of Medicine, 2011
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaNature, 2010
- Targeting Oncogenic BRAF in Human Cancer2010
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- Mutations of the BRAF gene in human cancerNature, 2002
- The MAP kinase cascade. Discovery of a new signal transduction pathwayMolecular and Cellular Biochemistry, 1993
- On the Origin of Cancer CellsScience, 1956